Adicet Bio Inc. is a biotechnology company focused on developing innovative cell therapies for cancer and other diseases
The company specializes in utilizing its proprietary technology to engineer immune cells, particularly gamma delta T cells, to effectively target and eradicate tumor cells. By harnessing the body's immune system, Adicet aims to create next-generation therapeutic solutions that can provide patients with more effective and personalized treatments, thereby advancing the field of immunotherapy and improving outcomes in oncology.
IN8bio (NASDAQINAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these cells to effectively target and eliminate cancer cells in both solid and hematological tumors.
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Shares of Mobileye Global Inc. (NASDAQMBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42. The S&P 500, also rose, gaining, 1.22% to 4,381.53.
